Automatic application of manufacturer coupons at checkout, when available, can significantly lower costs for some brand-name medications
That barrier could now fall sharply
2014;43(3):xviixviii
In addition to the regulatory challenges, the popularity of GLP-1 agonists for weight loss has also created a competitive market, with pharmaceutical companies racing to develop new versions of these drugs or alternative therapies that can address the demand for obesity treatment
While the mechanism is not yet proven, there is support for the idea that GLP-1 attenuates the ras homolog gene family, member A (RhoA)/Rho-associated protein kinase (ROCK) signaling pathway, whose activation is known to reduce levels of occludin, claudin-5, and zonula occludens-1 (ZO-1), as well as promote disruption of endothelial tight junctions
Protective effects of fucoidan against kidney diseases: pharmacological insights and future perspectives